1. Home
  2. ZNTL vs GENC Comparison

ZNTL vs GENC Comparison

Compare ZNTL & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZNTL
  • GENC
  • Stock Information
  • Founded
  • ZNTL 2014
  • GENC N/A
  • Country
  • ZNTL United States
  • GENC United States
  • Employees
  • ZNTL N/A
  • GENC N/A
  • Industry
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • GENC Construction/Ag Equipment/Trucks
  • Sector
  • ZNTL Health Care
  • GENC Industrials
  • Exchange
  • ZNTL Nasdaq
  • GENC Nasdaq
  • Market Cap
  • ZNTL 300.4M
  • GENC 305.0M
  • IPO Year
  • ZNTL 2020
  • GENC N/A
  • Fundamental
  • Price
  • ZNTL $4.31
  • GENC $21.96
  • Analyst Decision
  • ZNTL Buy
  • GENC
  • Analyst Count
  • ZNTL 7
  • GENC 0
  • Target Price
  • ZNTL $13.14
  • GENC N/A
  • AVG Volume (30 Days)
  • ZNTL 1.3M
  • GENC 41.4K
  • Earning Date
  • ZNTL 08-07-2024
  • GENC 08-07-2024
  • Dividend Yield
  • ZNTL N/A
  • GENC N/A
  • EPS Growth
  • ZNTL N/A
  • GENC 116.98
  • EPS
  • ZNTL N/A
  • GENC 1.15
  • Revenue
  • ZNTL $40,560,000.00
  • GENC $115,442,000.00
  • Revenue This Year
  • ZNTL N/A
  • GENC N/A
  • Revenue Next Year
  • ZNTL N/A
  • GENC N/A
  • P/E Ratio
  • ZNTL N/A
  • GENC $19.44
  • Revenue Growth
  • ZNTL N/A
  • GENC 5.87
  • 52 Week Low
  • ZNTL $3.27
  • GENC $13.50
  • 52 Week High
  • ZNTL $29.03
  • GENC $22.46
  • Technical
  • Relative Strength Index (RSI)
  • ZNTL 39.15
  • GENC 70.33
  • Support Level
  • ZNTL $3.59
  • GENC $20.10
  • Resistance Level
  • ZNTL $4.79
  • GENC $21.14
  • Average True Range (ATR)
  • ZNTL 0.44
  • GENC 0.62
  • MACD
  • ZNTL 0.29
  • GENC 0.29
  • Stochastic Oscillator
  • ZNTL 68.42
  • GENC 88.40

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.

Share on Social Networks: